{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T17:41:35Z","timestamp":1791394895820,"version":"4.3.3"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.pbb.2016.04.005","type":"journal-article","created":{"date-parts":[[2016,4,30]],"date-time":"2016-04-30T06:11:34Z","timestamp":1461996694000},"page":"35-43","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["HBK-7 \u2014 A new xanthone derivative and a 5-HT1A receptor antagonist with antidepressant-like properties"],"prefix":"10.1016","volume":"146-147","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7134-9515","authenticated-orcid":false,"given":"Karolina","family":"Pytka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grzegorz","family":"Kazek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agata","family":"Siwek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Mordyl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"G\u0142uch-Lutwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Rapacz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Olczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6176-0500","authenticated-orcid":false,"given":"Adam","family":"Ga\u0142uszka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Waszkielewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henryk","family":"Marona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacek","family":"Sapa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Filipek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u0142gorzata","family":"Zygmunt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pbb.2016.04.005_bb0005","first-page":"369-20","article-title":"Treatment-resistant depression: therapeutic trends, challenges, and future directions","volume":"6","author":"Al-harbi","year":"2012","journal-title":"PPA"},{"key":"10.1016\/j.pbb.2016.04.005_bb0010","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/0028-3908(71)90074-8","article-title":"Evaluation of a rapid technique for detecting minor tranquilizers","volume":"10","author":"Aron","year":"1971","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2016.04.005_bb0015","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ejphar.2003.09.064","article-title":"Anxiolytic-like effects of the selective 5-HT1A receptor antagonist WAY 100635 in non-human primates","volume":"482","author":"Barros","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pbb.2016.04.005_bb0020","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/0149-7634(94)00050-B","article-title":"Role of the serotonergic system in the forced swimming test","volume":"19","author":"Borsini","year":"1995","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.pbb.2016.04.005_bb0025","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S1056-8719(02)00166-1","article-title":"The power issue: determination of KB or Ki from IC50. A closer look at the Cheng-Prusoff equation, the Schild plot and related power equations","volume":"46","author":"Cheng","year":"2001","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.pbb.2016.04.005_bb0030","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","article-title":"Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction","volume":"22","author":"Cheng","year":"1973","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.pbb.2016.04.005_bb0035","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1177\/026988110101500401","article-title":"The lowest effective dose of fluoxetine in the forced swim test significantly affects the firing rate of lateral septal nucleus neurones in the rat","volume":"15","author":"Contreras","year":"2001","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.pbb.2016.04.005_bb0040","first-page":"104","article-title":"Recent advances in antidepressant drug treatment","volume":"131","author":"Ericksen","year":"1979","journal-title":"West. J. Med."},{"key":"10.1016\/j.pbb.2016.04.005_bb0045","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1055\/s-0035-1545841","article-title":"Antibacterial and antioxidant xanthones and benzophenone from Garcinia smeathmannii","volume":"81","author":"Fouotsa","year":"2015","journal-title":"Planta Med."},{"key":"10.1016\/j.pbb.2016.04.005_bb0050","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1254\/jjp.84.418","article-title":"Role of 5-HT1A receptors in a mouse passive avoidance paradigm","volume":"84","author":"Galeotti","year":"2000","journal-title":"Jpn. J. Pharmacol."},{"key":"10.1016\/j.pbb.2016.04.005_bb0055","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.neuropharm.2013.05.014","article-title":"Antidepressant and anxiolytic potential of the multimodal antidepressant vortioxetine (Lu AA21004) assessed by behavioural and neurogenesis outcomes in mice","volume":"73","author":"Guilloux","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2016.04.005_bb0060","first-page":"513","article-title":"Effects of theophylline in p-chlorophenylalanine-treated mice in a light\/dark test","volume":"18","author":"Imaizumi","year":"1996","journal-title":"Methods Find. Exp. Clin. Pharmacol."},{"key":"10.1016\/j.pbb.2016.04.005_bb0065","first-page":"461","article-title":"Central activity of new xanthone derivatives with chiral center in some pharmacological tests in mice","volume":"55","author":"Jastrz\u0119bska-Wi\u0119sek","year":"2003","journal-title":"Pol. J. Pharmacol."},{"issue":"Suppl. 2","key":"10.1016\/j.pbb.2016.04.005_bb0070","first-page":"S196","article-title":"Xanthones from mangosteen (Garcinia mangostana): multi-targeting pharmacological properties","volume":"97","author":"Jindarat","year":"2014","journal-title":"J. Med. Assoc. Thail."},{"key":"10.1016\/j.pbb.2016.04.005_bb0075","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1385\/MN:21:3:137","article-title":"The augmentation hypothesis for improvement of antidepressant therapy: is pindolol a suitable candidate for testing the ability of 5HT1A receptor antagonists to enhance SSRI efficacy and onset latency?","volume":"21","author":"Kinney","year":"2000","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.pbb.2016.04.005_bb0080","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0022-3565(25)27497-3","article-title":"p-Chlorophenylalanine: a specific depletor of brain serotonin","volume":"154","author":"Koe","year":"1966","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pbb.2016.04.005_bb0085","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/7854_2010_108","article-title":"Animal models of depression: molecular perspectives","volume":"7","author":"Krishnan","year":"2011","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"10.1016\/j.pbb.2016.04.005_bb0090","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.pbb.2015.11.013","article-title":"Antidepressant-like activity of aroxyalkyl derivatives of 2-methoxyphenylpiperazine and evidence for the involvement of serotonin receptor subtypes in their mechanism of action","volume":"141","author":"Kubacka","year":"2016","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2016.04.005_bb0095","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0022-3565(25)03549-9","article-title":"A simplified method of evaluating dose-effect experiments","volume":"96","author":"Litchfield","year":"1949","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pbb.2016.04.005_bb0100","article-title":"Antidepressant-like effects of two commercially available products of Hypericum perforatum in the forced swim test: a long-term study","author":"Lozano-Hernandez","year":"2010","journal-title":"J. Med."},{"key":"10.1016\/j.pbb.2016.04.005_bb0105","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s00210-007-0144-z","article-title":"Isobolographic analysis of interaction between drugs with nonparallel dose\u2013response relationship curves: a practical application","volume":"375","author":"Luszczki","year":"2007","journal-title":"Naunyn Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.pbb.2016.04.005_bb0110","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/sj.npp.1300602","article-title":"Pharmacological and behavioral characteristics of interactions between vigabatrin and conventional antiepileptic drugs in pentylenetetrazole-induced seizures in mice: an isobolographic analysis","volume":"30","author":"Luszczki","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2016.04.005_bb0115","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s00210-008-0349-9","article-title":"Isobolographic characterization of interactions of retigabine with carbamazepine, lamotrigine, and valproate in the mouse maximal electroshock-induced seizure model","volume":"379","author":"Luszczki","year":"2008","journal-title":"Naunyn Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.pbb.2016.04.005_bb0120","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.ejphar.2013.10.020","article-title":"European journal of pharmacology","volume":"720","author":"Luszczki","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pbb.2016.04.005_bb0125","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1124\/jpet.105.092262","article-title":"5-Hydroxytryptamine 1A receptor blockade facilitates aversive learning in mice: interactions with cholinergic and glutamatergic mechanisms","volume":"316","author":"Madjid","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pbb.2016.04.005_bb0130","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.pnpbp.2013.06.012","article-title":"Antidepressant-like effect of \u03b1-tocopherol in a mouse model of depressive-like behavior induced by TNF-\u03b1","volume":"46","author":"Manosso","year":"2013","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pbb.2016.04.005_bb0135","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1017\/S0033291713001475","article-title":"Somatodendritic 5-hydroxytryptamine1A (5-HT1A) autoreceptor function in major depression as assessed using the shift in electroencephalographic frequency spectrum with buspirone","volume":"44","author":"McAllister-Williams","year":"2013","journal-title":"Psychol. Med."},{"key":"10.1016\/j.pbb.2016.04.005_bb0140","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.neulet.2008.03.013","article-title":"Serotonergic mediation of the antidepressant-like effect of the green leaves odor in mice","volume":"436","author":"Nakatomi","year":"2008","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.pbb.2016.04.005_bb0145","doi-asserted-by":"crossref","first-page":"148","DOI":"10.2174\/187152410791196341","article-title":"New insight into the therapeutic role of 5-HT1A receptors in central nervous system disorders","volume":"10","author":"Ohno","year":"2010","journal-title":"Cent. Nerv. Syst. Agents Med. Chem."},{"key":"10.1016\/j.pbb.2016.04.005_bb0150","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0893-133X(00)00196-2","article-title":"Role of 5-HT1A and 5-HT1B receptors in the mediation of behavior in the forced swim test in mice","volume":"24","author":"O'Neill","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2016.04.005_bb0155","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/S0022-3565(24)37161-7","article-title":"Neurotransmitter receptor and transporter binding profile of antidepressants and their metabolites","volume":"283","author":"Owens","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pbb.2016.04.005_bb0160","doi-asserted-by":"crossref","DOI":"10.1111\/jphp.12305","article-title":"Novel tricyclic[2,1-f]theophylline derivatives of LCAP with activity in mouse models of affective disorders","author":"Partyka","year":"2014","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.pbb.2016.04.005_bb0165","first-page":"1","article-title":"Neuroprotective effects of xanthone derivative of Garcinia mangostana against lead-induced acetylcholinesterase dysfunction and cognitive impairment","author":"Phyu","year":"2014","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.pbb.2016.04.005_bb0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0142499","article-title":"Antidepressant- and anxiolytic-like effects of new dual 5-HT1A and 5-HT7 antagonists in animal models","volume":"10","author":"Pytka","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.pbb.2016.04.005_bb0175","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.pharep.2014.08.016","article-title":"Antidepressant-like activity of a new piperazine derivative of xanthone in the forced swim test in mice: the involvement of serotonergic system","volume":"67","author":"Pytka","year":"2015","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.pbb.2016.04.005_bb0180","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.ejphar.2015.07.041","article-title":"The antidepressant-like activity of 6-methoxy-2-[4-(2-methoxyphenyl)piperazin-1-yl]-9H-xanthen-9-one involves serotonergic 5-HT1A and 5-HT2A\/C receptors activation","volume":"764","author":"Pytka","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pbb.2016.04.005_bb0185","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.pharep.2015.08.007","article-title":"The role of serotonergic, adrenergic and dopaminergic receptors in antidepressant-like effect","volume":"68","author":"Pytka","year":"2016","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.pbb.2016.04.005_bb0190","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ejphar.2014.04.010","article-title":"Antiarrhythmic, hypotensive and \u03b11-adrenolytic properties of new 2-methoxyphenylpiperazine derivatives of xanthone","volume":"735","author":"Rapacz","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pbb.2016.04.005_bb0195","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.pharep.2015.03.011","article-title":"Antiarrhythmic activity of new 2-methoxyphenylpiperazine xanthone derivatives after ischemia\/reperfusion in rats","volume":"67","author":"Rapacz","year":"2015","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.pbb.2016.04.005_bb0200","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0014-2999(94)90124-4","article-title":"Anxiolytic-like effect of (S)-WAY 100135, a 5-HT1A receptor antagonist, in the murine elevated plus-maze test","volume":"261","author":"Rodgers","year":"1994","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pbb.2016.04.005_bb0205","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.pneurobio.2009.01.009","article-title":"5-HT(1A) receptor function in major depressive disorder","volume":"88","author":"Savitz","year":"2009","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.pbb.2016.04.005_bb0210","doi-asserted-by":"crossref","first-page":"105","DOI":"10.32607\/20758251-2013-5-4-105-109","article-title":"Antidepressant effect of dimeric dipeptide GSB-106, an original low-molecular-weight mimetic of BDNF","volume":"5","author":"Seredenin","year":"2013","journal-title":"Acta Nat."},{"key":"10.1016\/j.pbb.2016.04.005_bb0215","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.pharep.2013.12.002","article-title":"The effects of new sigma (\u03c3) receptor ligands, PB190 and PB212, in the models predictive of antidepressant activity","volume":"66","author":"Skuza","year":"2014","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.pbb.2016.04.005_bb0220","doi-asserted-by":"crossref","first-page":"7394","DOI":"10.1523\/JNEUROSCI.18-18-07394.1998","article-title":"Increase in serotonin-1A autoreceptors in the midbrain of suicide victims with major depression-postmortem evidence for decreased serotonin activity","volume":"18","author":"Stockmeier","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pbb.2016.04.005_bb0225","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1001\/jamapsychiatry.2014.2406","article-title":"Positron emission tomography quantification of serotonin(1A) receptor binding in suicide attempters with major depressive disorder","volume":"72","author":"Sullivan","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.pbb.2016.04.005_bb0230","doi-asserted-by":"crossref","first-page":"6714","DOI":"10.1016\/j.bmc.2015.09.005","article-title":"Cardiovascular activity of the chiral xanthone derivatives","volume":"23","author":"Szkaradek","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.pbb.2016.04.005_bb0235","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.brainresbull.2008.08.012","article-title":"Involvement of adrenergic and serotonergic receptors in antidepressant-like effect of urocortin 3 in a modified forced swimming test in mice","volume":"77","author":"Tanaka","year":"2008","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.pbb.2016.04.005_bb0240","first-page":"655","article-title":"Functional assays for screening GPCR targets","volume":"16","author":"Thomsen","year":"2005","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.pbb.2016.04.005_bb0245","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/sj.npp.1300080","article-title":"Modulation of passive avoidance in mice by the 5-HT1A receptor agonist flesinoxan: comparison with the benzodiazepine receptor agonist diazepam","volume":"28","author":"Tsuji","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2016.04.005_bb0250","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/321864a0","article-title":"Benzodiazepine impairs and beta-carboline enhances performance in learning and memory tasks","volume":"321","author":"Venault","year":"1986","journal-title":"Nature"},{"key":"10.1016\/j.pbb.2016.04.005_bb0255","doi-asserted-by":"crossref","first-page":"4419","DOI":"10.1016\/j.bmcl.2013.05.062","article-title":"Synthesis and evaluation of pharmacological properties of some new xanthone derivatives with piperazine moiety","volume":"23","author":"Waszkielewicz","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.pbb.2016.04.005_bb0260","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/cbdd.12394","article-title":"Synthesis and evaluation of antidepressant-like activity of some 4-substituted 1-(2-methoxyphenyl)piperazine derivatives","volume":"85","author":"Waszkielewicz","year":"2015","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.pbb.2016.04.005_bb0265","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1039\/C4NP00050A","article-title":"Xanthone dimers: a compound family which is both common and privileged","volume":"32","author":"Wezeman","year":"2015","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.pbb.2016.04.005_bb0270","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1016\/j.bmcl.2015.04.031","article-title":"Novel natural-product-like caged xanthones with improved druglike properties and in vivo antitumor potency","volume":"25","author":"Wu","year":"2015","journal-title":"Bioorg. Med. Chem. Lett."}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305716300582?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305716300582?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T23:14:45Z","timestamp":1748906085000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091305716300582"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":54,"alternative-id":["S0091305716300582"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2016.04.005","relation":{},"ISSN":["0091-3057"],"issn-type":[{"value":"0091-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HBK-7 \u2014 A new xanthone derivative and a 5-HT1A receptor antagonist with antidepressant-like properties","name":"articletitle","label":"Article Title"},{"value":"Pharmacology Biochemistry and Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pbb.2016.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}